NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

Organon & Co. OGN | NYSE

$13.84 $0.03 | 0.22%
TREND SIGNAL:Signal available — unlock to view |2026-10-07

Next Earnings: Nov 09, 2026

Company Overview:

Market Cap: $3.63B
Trailing PE: 18x
FWD PE *: 4x
Payout Ratio (TTM): 8.6%
52-Week Range: $5.69 - $13.84

* Forward PE is based on street estimates.

5.5 Year OGN Performance Metrics:

Total Return (with DRIP): -48.8% (-11.46% CAGR)
Total Return (no DRIP): -45.4% (-10.41% CAGR)
Share Price: -58.4% (-14.73% CAGR)
Yield on Cost (with DRIP): 0.30%
Total Invested: $10,000
Total Value (with DRIP): $5,119
Total Return $ (with DRIP): -$4,881
Dividend Increase: -92.9% (-41.12% CAGR)
Dividend Yield (FWD): 0.58% ($0.08)
OGN 5.5-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
OGN Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
OGN Price CAGR:1Y: 110.65%2Y: -12.14%5Y: -17.74%10Y: -14.83%
OGN Dividend Charts
OGN - Dividends
OGN Dividend CAGR:1Y: 0.00%2Y: -73.27%5Y: -41.01%10Y: -41.12%
OGN - Dividend Payout Ratio
OGN Dividend Payout Ratio CAGR:1Y: -19.44%2Y: -62.97%5Y: 0.00%10Y: 0.00%
OGN - Dividend to Free Cash Flow Ratio
OGN Dividend to FCF Ratio CAGR:1Y: 67.08%2Y: -40.79%5Y: 0.00%10Y: 0.00%
Build Custom Charts
OGN - Chart 1
OGN - Chart 2
OGN - Chart 3

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

OGN Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

OGN - Revenue
OGN Revenue CAGR:1Y: -2.26%2Y: -1.54%5Y: -0.75%10Y: 0.00%
OGN - Earnings Per Share (EPS)
OGN EPS CAGR:1Y: -28.57%2Y: -26.97%5Y: -24.95%10Y: 0.00%
OGN - Net Income
🔓 See the full chart40% off right now · 7-day free trial
OGN Net Income CAGR:1Y: -25.52%2Y: -25.58%5Y: -24.04%10Y: 0.00%
OGN - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
OGN EBITDA CAGR:1Y: -17.37%2Y: -7.33%5Y: -7.30%10Y: 0.00%
OGN - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
OGN Free Cash Flow CAGR:1Y: -64.09%2Y: -53.45%5Y: -45.98%10Y: 0.00%
OGN - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
OGN Free Cash Flow / Share CAGR:1Y: -64.45%2Y: -53.93%5Y: -46.36%10Y: 0.00%
OGN - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
OGN Operating Income CAGR:1Y: -0.92%2Y: -8.52%5Y: -9.87%10Y: 0.00%
OGN - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
OGN Gross Profit CAGR:1Y: -3.09%2Y: -5.03%5Y: -3.93%10Y: 0.00%
OGN - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
OGN Shares Outstanding CAGR:1Y: 3.96%2Y: 2.27%5Y: 1.28%10Y: 0.00%
OGN - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
OGN Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
OGN - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
OGN Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
OGN - Expenses
🔓 See the full chart40% off right now · 7-day free trial
OGN Expenses CAGR:1Y: 7.69%2Y: 14.56%5Y: -6.57%10Y: 0.00%
OGN - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
OGN - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
OGN - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
OGN - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
OGN - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
OGN - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
OGN - Revenue by Region
🔓 See the full chart40% off right now · 7-day free trial
OGN Revenue CAGR:1Y: -2.26%2Y: -1.54%5Y: -0.75%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

OGN - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
OGN Actual Revenue CAGR:1Y: -2.26%2Y: -1.54%5Y: -0.75%10Y: 0.00%
OGN - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
OGN Actual EPS CAGR:1Y: -28.57%2Y: -26.97%5Y: -24.95%10Y: 0.00%
OGN - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
OGN Actual Net Income CAGR:1Y: -25.52%2Y: -25.58%5Y: -24.04%10Y: 0.00%
OGN - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
OGN Actual EBITDA CAGR:1Y: -17.37%2Y: -7.33%5Y: -7.30%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

OGN - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
OGN Net Profit Margin CAGR:1Y: -23.85%2Y: -24.41%5Y: -23.47%10Y: 0.00%
OGN - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
OGN Gross Profit Margin CAGR:1Y: -0.86%2Y: -3.55%5Y: -3.20%10Y: 0.00%
OGN - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
OGN Price to Earnings CAGR:1Y: 91.05%2Y: 11.17%5Y: 12.89%10Y: 0.00%
OGN - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
OGN Price To Sales Ratio CAGR:1Y: 44.58%2Y: -16.22%5Y: -13.60%10Y: 0.00%
OGN - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
OGN Return on Capital Employed CAGR:1Y: 0.41%2Y: -13.71%5Y: -14.88%10Y: 0.00%
OGN - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
OGN Return on Invested Capital CAGR:1Y: -6.06%2Y: -27.44%5Y: -23.10%10Y: 0.00%

Compare stocks side-by-side

OGN Dividends Info:

Annual Dividend: $0.08
Forward Yield: 0.58%
Ex-Dividend Date: 2026-08-14
Lifetime Dividends / Share: $4.32

OGN Dividend History: Dates, Payments & Yield list

Below is a schedule of all OGN dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
08/14/202608/17/2026$0.0200.58%0.58%$13.70
05/11/202605/13/2026$0.0200.6%0.6%$13.34
02/23/202602/25/2026$0.0201.01%1.07%$7.51
11/20/202511/24/2025$0.0201.12%1.13%$7.06
08/15/202508/18/2025$0.0200.85%0.86%$9.28
05/12/202505/14/2025$0.0200.92%1%$8.04
02/24/202502/26/2025$0.2807.43%7.24%$15.48
11/12/202411/14/2024$0.2807.19%7.32%$15.31
08/16/202408/19/2024$0.2805.5%5.34%$20.96
05/10/202405/13/2024$0.2805.48%5.35%$20.94
02/23/202402/26/2024$0.2806.05%6.35%$17.65
11/10/202311/13/2023$0.28010.07%10.15%$11.03
08/17/202308/21/2023$0.2804.99%5%$22.40
05/12/202305/15/2023$0.2805.37%5.37%$20.84
02/24/202302/27/2023$0.2804.38%4.46%$25.09
11/10/202212/15/2022$0.2804.53%3.96%$28.28
08/12/202209/15/2022$0.2803.61%3.9%$28.75
05/13/202206/16/2022$0.2803.21%3.41%$32.81
02/25/202203/17/2022$0.2802.98%3.26%$34.34
11/19/202112/16/2021$0.2803.58%3.69%$30.33
08/20/202109/13/2021$0.2803.37%3.31%$33.83

Projected Future Returns & Dividends for OGN

Based on past 5.5-year performance, here are OGN growth metrics:

Share price CAGR of -14.73%
Dividend CAGR of -41.48%

Using OGN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

OGN (DRIP)OGN - No DRIP
Current Price$13.84$13.84
Start Shares722.54722.54
Start Value$10,000$10,000
  
After 10 years:
Final Share Count735.66722.54
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$2.81$2.81
Total Dividends$140$139
Final Value$2,069$2,171

Estimated Future Value + Dividends - OGN

NOTE: Above numbers are our estimate based on OGN's Dividend and Price CAGR over past 5.5 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

Company Info

Organon & Co. (OGN) had its IPO on 2021-05-14, and is traded on NYSE stock exchange.

Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collection includes three immune-related medications (Brenzys, Renflexis, Hadlima) and two cancer therapies (Ontruzant, Aybintio). Additionally, Organon provides cardiovascular medications, such as cholesterol-reducing drugs (Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, Zocor) and treatments for high blood pressure (Cozaar, Hyzaar). Their respiratory product line addresses asthma symptoms with brands like Singulair, Dulera, Zenhale, and Asmanex, and manages seasonal allergies through Singulair, Nasonex, Clarinex, and Aerius. Furthermore, their offerings extend to dermatological care (Diprosone, Elocon), bone strengthening (Fosamax), and non-narcotic pain relief (Arcoxia, Diprospan, Celestone). The portfolio also comprises Proscar for treating symptomatic benign prostatic hyperplasia and Propecia for combating male pattern hair loss. The company's products are primarily distributed to pharmaceutical wholesalers, retailers, medical facilities, government entities, and various managed healthcare organizations, including health maintenance organizations and pharmacy benefit managers. Organon & Co. was established in 2020 and is headquartered in Jersey City, New Jersey.

OGN website: https://www.organon.com


Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount
Loading signals…

DCF Model — OGN

Value from:
Pay up to today
—
vs current price $13.84
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →